Issuer Jurisdiction: United States

Use of Proceeds: Expansion of healthcare facilities and technology investment in United States.

Early Exit / Redemption Option: At maturity; early redemption possible after 12 months at 101% of nominal.

ISIN: Assigned

Capital Return Mechanism: At maturity; principal repaid from operating cash flow of the healthcare platform, with real estate collateral available as security

Accepted Investment Currencies: USD

The issuer operates an established healthcare platform focused on the operation, expansion and active management of medical facilities and specialised care services. Its business model is based on generating stable recurring revenue from patient services, insurance reimbursements and public health contracts, while increasing long-term value through disciplined facility management, service line optimisation and selective capacity expansion. Management has developed a scalable operating platform supported by professional clinical management, financial discipline and transparent reporting. The company continues to expand its footprint through targeted facility upgrades, technology investment and long-term contractual relationships with insurers and public health bodies, designed to strengthen recurring cash flow.

The commercial strategy focuses on expanding capacity at existing facilities and improving operational performance to enhance long-term platform value. This includes optimising patient throughput and service mix, investing in diagnostic and medical technology that supports revenue growth, and pursuing disciplined expansion while strengthening clinical management systems and long-term relationships with insurers, referral partners and public health authorities to improve income stability and operational resilience.

The healthcare sector continues to benefit from structural demand for specialised medical services, supported by demographic trends, technological advancement and institutional healthcare investment activity. These market conditions continue to create opportunities for experienced operators capable of combining disciplined clinical and financial management, efficient capital allocation and active service expansion while maintaining conservative financial management and transparent governance.

To support continued growth, the issuer has invested in experienced clinical and administrative management teams, modern diagnostic technology and internal reporting infrastructure. The operating model is built around diversified revenue streams, long-term payer relationships and disciplined cost management intended to improve operational performance while reducing concentration risk.

Proceeds from the financing will primarily support further expansion of healthcare facilities, investment in diagnostic and medical technology, recruitment of specialist staff and ongoing capital improvements. Additional resources may also be allocated to strengthening operational infrastructure, enhancing clinical capabilities and maintaining a conservative balance sheet while supporting long-term growth.

From an investment perspective, the opportunity is supported by recurring patient service revenue, diversified payer relationships and the long-term value of a professionally managed healthcare platform. Management believes that disciplined capacity expansion, active clinical management and stable demand levels provide an attractive foundation for sustainable cash generation over the medium and long term. The company continues to focus on preserving service quality, improving operational performance and creating additional value through selective facility expansion and active management.

Overall, the opportunity represents an established healthcare platform focused on recurring service revenue, disciplined facility management and sustainable value creation. Management continues to pursue conservative growth supported by active clinical and operational management, transparent reporting and prudent financial oversight while strengthening long-term relationships with payers, financing partners and institutional investors. The platform is designed to deliver stable operational performance together with long-term value appreciation, supported by real estate collateral securing the offering.

Company / Project Description:

The issuer operates in the healthcare sector, generating revenue through the operation of medical facilities under long-term service agreements with patients, insurers and public health bodies. The bond financing is intended to support ongoing facility expansion, capital investment in diagnostic technology and continued operational growth. Investors should primarily consider regulatory and reimbursement risks, staffing availability and general operational risks associated with the healthcare sector.

Revenue Generation Model:

Year Established: 1991

Number of Employees: 506

Key Markets: United States

Core Business Activity:

Operation of healthcare facilities and provision of medical services, diagnostics and specialised care.

Brief History:

Reason for Capital Raising:

Company Stage:

Ownership Structure:

Existing Financing: N/A